The stock price of Traws Pharma, Inc. (NASDAQ: TRAW) has experienced a notable increase, with shares rising by 143.03% to $12.20 in midday trade. This increase comes after the business revealed encouraging top-line findings from its Phase 1 clinical study of tivoxavir marboxil, an experimental one-dose treatment for H5N1 avian influenza or bird flu. Progress […]
Traws Pharma (TRAW) Shares Jump On Strong Trial Results Read More »
Following the news of a possible merger with Nissan, shares of Honda Motor Co., Ltd. (NYSE: HMC) are surging sharply on the US stock charts today. At $26.48, HMC stock was up 10.84% as of the last check, indicating that investors were confident in the calculated move. The Beginning of a Historic Collaboration In order
Honda Motor (HMC) Sees Stock Rise After Unveiling Merger Plan Read More »
As of the last check during the recent trading session, Phio Pharmaceuticals Corp. (NASDAQ: PHIO) shares were up 33.81% to $2.36, indicating a big increase in value today. The spike in PHIO stock is due to a recently announced equity offering and positive outcomes from clinical research. Inspiration Findings from the PH-762 Clinical Trial According
Phio Pharmaceuticals Rallies Following Key Trial and Funding Updates Read More »
After a merger deal was announced, shares of Despegar.com, Corp. (NYSE: DESP) surged 33.17% in pre-market trading to $19.51. Prosus, a well-known global technology business, will purchase it for cash for around $1.7 billion, according to DESP. A Landmark Deal The price per share that DESP stockholders will get is $19.50, a premium of 34%
Despegar (DESP) Shares Rally Pre-Hours On Acquisition Deal News Read More »
Pre-market trading for Rumble Inc. (NASDAQ: RUM) saw a notable uptick, with shares surging 40.89% to $10.13. This increase comes after Tether ($USDT), a pioneer in digital assets and the most popular dollar stablecoin with over 350 million users worldwide, announced a $775 million strategic investment. Plans for Growth and Investment Allocation The investment agreement
Rumble (RUM) Stock Climbs In Pre-Hour Trading Read More »
Shares of Sigma Lithium Corporation (NASDAQ: SGML) experienced a notable uptick following the announcement of a pivotal licensing achievement. SGML stock climbed 6.54% in the after-market session last Friday, reaching $11.73 per share. This development underscores growing investor confidence in the company’s strategic advancements. Triple Environmental License Secured for Barreiro Mine Sigma Lithium revealed that
Sigma Lithium (SGML) Sees After-Hour Boost Amid Regulatory Milestone Read More »
The stock performance of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) saw a notable uptick last week. Shares rose 8.14% during the regular session, closing at $3.19, and then 6.58% in after-hours trading to $3.40 on Friday. Notable advancements in the business’s revenue-generation tactics served as the catalyst for the rise. Strategic Alliances to Promote Development Recently,
Extended Session Gains Propel Cyclerion (CYCN) Amid Revenue Progress Read More »
Following a major regulatory approval, Humacyte, Inc.’s (NASDAQ: HUMA) shares surged 68.50% to $5.83 as of the last check during the pre-market trading session. The acellular, tissue-engineered vessel SYMVESS has received complete approval from the U.S. Food and Drug Administration (FDA) to treat people with arterial injuries in their extremities that need immediate revascularization, especially
Humacyte (HUMA) Stock Gains Pre-Market Momentum Following FDA Nod Read More »
After the announcement of a high-profile partnership, Mainz Biomed N.V. (NASDAQ: MYNZ) stock saw a sharp increase on Thursday. During the regular trading session, MYNZ shares increased 26.19%, finishing at $4.77. Still in the pre-market session today, the stock is on the rise of 14.05% to $5.44, reflecting investor confidence in the company’s new deal.
Mainz Biomed (MYNZ) Stock Soars In Pre-Hour Session On A New Partnership Read More »
BioAge Labs, Inc.’s (NASDAQ: BIOA) stock witnessed a significant uptick on Thursday, closing at $5.17 after increasing 20.23%. The announcement of a strategic, multi-year research partnership with Novartis to further its understanding of exercise biology and aging was the catalyst for this notable increase in stock value. Strategic Alliance with Novartis BioAge Labs unveiled a
BioAge (BIOA) Shares Climb On The Back Of Promising New Collaboration Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.